Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE: Face the sky...Drebbin-ease

RE: Face the sky...Drebbin-ease

posted on Mar 20, 2006 03:55PM
``How much money do we have now? 40 million and we are worth 1.60?``

Pardon my ignorance but I am on the periphery of this company`s current financial condition. I was under the impression their current take was in the neighborhood of $24 million.

Is $40 million now the current take from announced settlements?

What I will tell you is that evaluating a company in its growth phase is very different from evaluations in later stages of development, partially because no one can yet monitize the level of growth.

Should they knock down several more notables in the relative short term with similar success as we have seen, there will continue to be an increasing awareness of ptsc that will further drive the pps.

However, should this be all she wrote, they are still sitting pretty with millions and no overhead...plenty of room to build and grow on but not nearly the jet fuel more deals will provide to the pps...and the dividend decision won`t be looking like a good decision...which leads me to believe they are rather confident of the direction of future events.

TIA

Share
New Message
Please login to post a reply